Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

SHE:002940 Revenue

Zhejiang AngLiKang Pharmaceutical CO.,LTD. had revenue of 273.08M CNY in the quarter ending September 30, 2026, a decrease of -17.45%. This brings the company's total for the last twelve months to 1.27B, down -13.71% year-over-year. In the year 2025, Zhejiang AngLiKang Pharmaceutical CO.,LTD. had annual revenue of 1.42B, down -7.35%. That makes Zhejiang AngLiKang Pharmaceutical CO.,LTD. the 17,843rd largest company in the world by revenue and 3,254th in China.

• Revenue (ttm): 1.27B
• Revenue Growth: -13.71%
• P/S Ratio: 3.79
• Revenue / Employee: 1.03M
• Employees: 1,236
• Market Cap: 4.61B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Preparations 677.86M 47.6%
• Raw Materials 575.86M 40.4%
• Specialty Intermediates 139.94M 9.8%
• Others 31.14M 2.2%

By Geography

Chart

• China 1.11B 77.9%
• Overseas 314.27M 22.1%

Fiscal year ended Dec 31, 2025 See the full SHE:002940 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.42B	-113.07M	-7.35%
Dec 31, 2024	1.54B	-82.69M	-5.10%
Dec 31, 2023	1.62B	52.13M	3.32%
Jan 1, 2023	1.57B	188.06M	13.62%
Jan 1, 2022	1.38B	90.73M	7.04%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error